Cashmere goat lncRNA, interference vector and application thereof in regulating cashmere goat cashmere growth

By constructing the interfering vector of lncRNA MSTRG.3144.1, regulating dermal fibroblasts, solving the lack of hair follicles in the embryonic stage of velvet goats, significantly promoting the growth of cashmere in the velvet goats, and providing a basis for research on the molecular mechanism of action.

CN118703502BActive Publication Date: 2024-11-22INNER MONGOLIA AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411186445.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-11-22
Estimated Expiration
2044-08-28

AI Technical Summary

Technical Problem

There is a lack of research on the molecular mechanism of hair follicles in the embryonic stage of the velvet goat, and the lack of excavation of key regulatory factors, which affects the progress of research on the early growth and development of velvet goat velvet goat.

Method used

By constructing the interfering vector of lncRNA MSTRG.3144.1, the cell cycle, proliferation and migration in dermal fibroblasts were regulated, and the role of lncRNA MSTRG was detected using DNA staining, CCK8 method and scratch tests to explore lncRNA MSTRG. 3144.1 Co-expression regulation network with THEM4/THEM5.

Benefits of technology

It significantly inhibits the proliferation and migration of dermal fibroblasts, regulates hair follicle development, promotes the growth of cashmere in velvet goats, and provides a basis for the study of the molecular mechanism of hair follicles in the embryonic stage of velvet goats.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118703502B_ABST
    Figure CN118703502B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of genetic engineering technology, and specifically relates to a cashmere goat lncRNA, an interference vector and an application thereof in regulating the growth of cashmere goats. The lncRNA is lncRNA MSTRG-3144.1, and the nucleotide sequence of the lncRNA MSTRG-3144.1 is shown in SEQ ID NO.1. The present invention selects dermal fibroblasts for subsequent experimental verification. Based on the constructed lncRNA MSTRG.3144.1- THEM4 / THEM5 The co-expression regulatory network was constructed by interfering with lncRNA MSTRG.3144.1 and stably transfecting dermal fibroblast cell lines, and qRT-PCR was used to detect the interaction between lncRNA MSTRG.3144.1 and THEM5 / THEM4 In terms of regulatory relationship at the cellular level, DNA staining, CCK8 method and scratch test were used to detect the cell cycle, cell proliferation and cell migration of dermal fibroblasts.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a cashmere goat lncRNA, an interference vector and applications thereof in regulating cashmere goat cashmere growth. Background Art

[0002] Cashmere produced by cashmere goats is soft to the touch and has good glossiness, and is a high-grade textile raw material. The characteristics of the skin and hair follicle structure of cashmere goats are not only important contents of their biological characteristics, but also have a direct impact on the yield and quality of cashmere.

[0003] Dermal fibroblasts play an important role in the early development of hair follicles. When the induction signal is transmitted to the dermis, the dermal fibroblasts in the dermis aggregate in a directional manner to form dermal condensates. As the hair follicles continue to grow downward, the dermal condensates further differentiate into hair papillae, which can induce the growth and regeneration of hair follicles.

[0004] At present, most of the research on hair follicles focuses on the cyclical growth of adult wool follicles, while there are very few studies on the growth and development of early hair follicles. At the same time, compared with other livestock species, the research on genes, proteins and their mechanisms of action related to important economic traits of cashmere goat hair follicles is still relatively weak, especially in the research on the molecular mechanism of hair follicle development in the embryonic stage of cashmere goats and the mining of related factors. Therefore, it is urgent to carry out research on the molecular mechanism of hair follicle development in the embryonic stage of cashmere goats, to explore the key regulatory factors, to provide a basis for the research on early hair follicle growth and development, which is of great significance to accelerate the progress of molecular breeding of cashmere goats. Summary of the invention

[0005] In order to solve the problem of lack of research on the molecular mechanism of hair follicle development in the embryonic stage of cashmere goats in the prior art, and to achieve the above-mentioned purpose, the present invention adopts the following technical solution:

[0006] The present invention selects dermal fibroblasts for subsequent experimental verification. Based on the constructed lncRNAMSTRG.3144.1- THEM4 / THEM5 The co-expression regulatory network is constructed by interfering with lncRNA MSTRG.3144.1 to stably transform dermal fibroblast cell lines. THEM5 / THEM4 In the regulatory relationship at the cellular level, DNA staining, CCK8 method and scratch test are used to detect the cell cycle, cell proliferation and cell migration of dermal fibroblasts. Based on this, the present invention provides a cashmere goat lncRNA, an interference vector and its application in regulating the growth of cashmere goats.

[0007] The first object of the present invention is to provide a cashmere goat lncRNA, wherein the cashmere goat lncRNA is lncRNAMSTRG-3144.1, and the nucleotide sequence of the lncRNA MSTRG-3144.1 is shown in SEQ ID NO. 1. lncRNAMSTRG-3144.1 is a non-coding RNA with a length of 325 nt and does not have the ability to encode proteins.

[0008] Preferably, the PCR primers for the cashmere goat lncRNA include an upstream primer and a downstream primer, the nucleotide sequence of the upstream primer is shown in SEQ ID NO.2: GGCGGGCTACAGTCCATAGG; the nucleotide sequence of the downstream primer is shown in SEQ ID NO.3: TGGCTGAAGGTCTGGAGTGTTG.

[0009] The second object of the present invention is to provide an interference vector containing the cashmere goat lncRNA.

[0010] Preferably, the interference vectors containing the cashmere goat lncRNA are shMSTRG.3144.1_1 and shMSTRG.3144.1_2. According to the test results of the present invention, both the interference vectors shMSTRG.3144.1_1 and shMSTRG.3144.1_2 have significant interference effects, so these two interference vectors can be selected, and the subsequent tests are conducted by randomly selecting the vectors.

[0011] The third object of the present invention is to provide the use of the cashmere goat lncRNA or the interference vector of the cashmere goat lncRNA in regulating the growth of cashmere goats.

[0012] Preferably, the expression of the cashmere goat lncRNA is inhibited by the interference vector of the cashmere goat lncRNA to promote the growth of cashmere goat cashmere.

[0013] Preferably, the cashmere goat lncRNA interference vector is used to promote the development of hair follicles, thereby promoting the growth of cashmere goats' cashmere.

[0014] Specifically, the cashmere goat lncRNA expression level in the entire dermal fibroblast cell line can be reduced by an interference vector containing the cashmere goat lncRNA.

[0015] The cashmere goat lncRNA provided by the present invention regulates the growth of cashmere goat cashmere by regulating the development of hair follicles.

[0016] Preferably, the growth of cashmere goats' cashmere is promoted by regulating the development of hair follicles through any of the following methods:

[0017] The expression of the cashmere goat lncRNA MSTRG-3144.1 is inhibited to inhibit the dermal fibroblast cell cycle.

[0018] The expression of the cashmere goat lncRNA MSTRG-3144.1 is inhibited to inhibit the proliferation of dermal fibroblasts.

[0019] The expression of the cashmere goat lncRNA MSTRG-3144.1 is inhibited to inhibit the migration of dermal fibroblasts.

[0020] Inhibiting the expression of the cashmere goat lncRNA MSTRG-3144.1 to promote the expression of mRNA related to the proliferation or migration of dermal fibroblasts; the mRNA includes THEM4 , THEM5 . HEM4 and THEM5 Both genes are key components of the PI3K-AKT signaling pathway in hair follicle growth and development, with lengths of 1417nt and 1025nt respectively.

[0021] Inhibiting the expression of lncRNA MSTRG-3144.1 to regulate dermal fibroblast proliferation or migration-related genes, wherein the dermal fibroblast proliferation or migration-related genes include CCNE1 , CCND1 , CDK2 , CDK4 , CDK6 and p53 .

[0022] The present invention achieves interference with lncRNA MSTRG-3144.1 through the cashmere goat lncRNA interference vector.

[0023] Specifically, the dermal fibroblasts are dermal fibroblasts in the early growth and development of cashmere goat hair follicles. During the early growth and development of cashmere goat hair follicles, the proliferation or migration of dermal fibroblasts can promote the formation of hair follicle dermal condensates and dermal papillae.

[0024] Preferably, the expression of lncRNA MSTRG-3144.1 is regulated for proliferation or migration of dermal fibroblasts. By regulating the expression of lncRNA MSTRG-3144.1 in dermal fibroblasts, the state of cell proliferation and migration of dermal fibroblasts under different expression conditions of lncRNA MSTRG-3144.1 can be determined.

[0025] Preferably, the interference vector of cashmere goat lncRNA is used to prepare a product for inhibiting the proliferation or migration of dermal fibroblasts.

[0026] Preferably, the product for regulating the proliferation or migration of dermal fibroblasts includes a substance for overexpressing lncRNAMSTRG-3144.1 and / or a substance for silencing lncRNA MSTRG-3144.1. By overexpressing lncRNAMSTRG-3144.1 and / or silencing lncRNA MSTRG-3144.1, the proliferation or migration state of dermal fibroblasts in the early growth and development of cashmere goat hair follicles is regulated, thereby affecting the growth and development of early hair follicles.

[0027] Compared with the prior art, the present invention has the following beneficial effects:

[0028] 1. The present invention provides a cashmere goat lncRNA, an interference vector and its application in regulating cashmere goat cashmere growth. The cashmere goat lncRNA provided by the present invention is lncRNA MSTRG-3144.1, and the nucleotide sequence of its cDNA is shown in SEQ ID NO.1. The research results of the present invention show that: lncRNA MSTRG.3144.1 has an effect on THEM4 , THEM5 The lncRNA MSTRG.3144.1 can inhibit cell proliferation by regulating the cell cycle process. The lncRNA MSTRG.3144.1 can inhibit cell migration. The present invention selects dermal fibroblasts for subsequent experimental verification. Based on the lncRNA MSTRG.3144.1 constructed by the research institute, THEM4 / THEM5 The co-expression regulatory network was constructed by interfering with lncRNA MSTRG.3144.1 and stably transfecting dermal fibroblast cell lines, and qRT-PCR was used to detect the interaction between lncRNA MSTRG-3144.1 and THEM5 / THEM4 In terms of regulatory relationship at the cellular level, DNA staining, CCK8 method and scratch test were used to detect the cell cycle, cell proliferation and cell migration of dermal fibroblasts.

[0029] 2. The results of the present invention found that lncRNA MSTRG.3144.1 mediates THEM4 and THEM5 Participates in the development of secondary hair follicles. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 To construct the lncRNA MSTRG 3144.1 interference stable dermal fibroblast cell line in the present invention, wherein, Figure 1 A in the figure is the FITC protein fluorescence result of each experimental group; Figure 1B in the figure is the relative expression result diagram of lncRNA MSTRG.3144.1 in each experimental group.

[0031] Figure 2 For the present invention THEM4 and TEHM5 The relative expression levels in dermal fibroblast cell lines, among which, Figure 2 A in THEM4 The relative expression level of Figure 2 B in THEM5 The relative expression level.

[0032] Figure 3 The DNA staining method of the present invention is used to detect the dermal fibroblast cell cycle, wherein: Figure 3 A in the figure is the flow cytometry analysis cycle result diagram of shMSTR.3144.1; Figure 3 B in the figure is the flow cytometry analysis cycle result diagram of shRNA_NC; Figure 3 C in the figure is the statistical analysis of dermal fibroblast cell cycle, *** indicates P < 0.001; Figure 3 D in it is the proliferation index of dermal fibroblasts.

[0033] Figure 4 The CCK8 method of the present invention is used to detect cell proliferation.

[0034] Figure 5 The cell migration result detected by the cell scratch test in the present invention, wherein: Figure 5 A in the figure is the result of cell scratch test; Figure 5 B in the figure is the cell migration rate of dermal fibroblast cell line, * indicates P < 0.05; Figure 5 C in the figure is the result of detecting the proliferation of dermal fibroblasts after 24 hours of serum-free culture using the CCK8 method. DETAILED DESCRIPTION

[0035] The present invention is described in detail below in conjunction with the accompanying drawings and specific examples, but should not be construed as limiting the present invention. Unless otherwise specified, the technical means used in the following examples are conventional means well known to those skilled in the art, and the materials, reagents, etc. used in the following examples, unless otherwise specified, can be obtained from commercial sources.

[0036] Example 1

[0037] 1. Instruments, Materials and Reagents

[0038] 1. Test samples:

[0039] The dermal fibroblasts were obtained by subsequent tissue culture of embryonic lateral skin tissue collected by Inner Mongolia Jinlai Animal Husbandry Technology Co., Ltd. Among them, the conditions / methods of tissue culture are to cut the fresh tissue into meat paste, take 1 / 2 soybean-sized dots into the cell culture bottle, add DMEM / F12 medium containing 10% fetal bovine serum and 1% triple antibody by mass concentration, culture in a 37°C, 5% CO2 incubator until the cells crawl out, and freeze for later use.

[0040] The lncRNA interference MSTRG.3144.1 viral vector, also known as lentiviral vector, comes from Shanghai GeneCare Gene Medicine Technology Co., Ltd.

[0041] 2. Main instruments, equipment and reagents:

[0042] Inverted fluorescence microscope: Olympus, China; mini centrifuge: Qilin Bell, China; fully automatic ultrapure water instrument: Purelab ELGALA-611; ELx800 multifunctional microplate reader: BioTek, USA; cell counter: Cytorecon-1000, China; pressure cooker, autoclave: Panasonic mLS-375, Japan;

[0043] -80℃ ultra-low temperature freezer: Thermo, China; CO2 saturated humidity incubator: RsBiotech, UK; pipette: Eppendorf, USA; DMEM / F12 medium, DMEM complete medium: Gibco, USA; fetal bovine serum, FBS: Gibco, USA; RNase free pipette tip: Axygen, USA; tertiary antibody: Gibco, China; RNAiso Plus: Takara, China; 0.25% trypsin: containing EDTA: Gibco, China; PBS buffer: mass concentration of 10%, pH 7.4, Gibco, China; DMSO, for freezing cells: Sigma, USA; epidermal growth factor: Gibco, China; eight-tube strip: Di En Biotechnology, China; real-time quantitative PCR instrument: ABI, USA; CCK8 kit: Solarbio, China.

[0044] 2. Methods

[0045] 1. Recovery and culture of dermal fibroblasts

[0046] Take out the cryopreservation tube of dermal fibroblasts from liquid nitrogen, put it in a 37°C water bath, and shake it quickly until it dissolves; transfer the cell suspension of dermal fibroblasts in the cryopreservation tube to a 15mL centrifuge tube, add 2mL of preheated DMEM / F12 medium containing 10% fetal bovine serum and 1% triple antibody by mass concentration, mix well, and centrifuge at 1500rpm for 5 minutes; discard the supernatant, add 2mL of preheated DMEM complete medium to resuspend the cells; transfer all the cell suspension in the 15mL centrifuge tube to the culture bottle, and continue to add 2mL of DMEM complete medium; shake the culture bottle in an eight-shaped shape until the cell suspension is mixed, and culture it in a 37°C, 5% CO2 incubator.

[0047] 2. Lentiviral transfection of dermal fibroblasts

[0048] Dermal fibroblasts were seeded in a 6-well plate and incubated at 37°C with 5% CO2 until the confluence of the seeded cells reached 30%; the medium was replaced with serum-free DMEM / F12 medium and HitransG P virus infection enhancement solution was added. The dosage standard of HitransG P virus infection enhancement solution is shown in Table 1.

[0049] According to the preliminary experimental results, MOI=10 was used to calculate the virus dosage, and the calculation formula was: virus volume = (MOI×number of cells) / virus titer. 1 μL of virus and 1 ml of serum-free DMEM / F12 medium were added and cultured in an incubator at 37°C and 5% CO2 by volume; after 15 hours of culture, the medium was replaced with DMEM / F12 medium containing 10% serum and 1% antibody by mass, and the culture was continued for about 72 hours to observe the transfection efficiency; puromycin was added to the cell lines with good transfection efficiency for anti-positive screening for 24 hours, and the final concentration was 5 μg / mL.

[0050] Among them, good transfection efficiency means that the ratio of the number of cells expressing the target protein in the successfully transfected cells to the total number of transfected cells is high.

[0051] It should be noted that the lentiviral vector was constructed and packaged by Shanghai GeneCare Gene Medical Technology Co., Ltd. Two lentiviral vectors containing lncRNA MSTRG.3144.1 were constructed: shRNA interference vectors, named shMSRTG.3144.1_1 and shMSRTG.3144.1_2, and shRNA negative control, named sh-NC.

[0052] Among them, the shRNA negative control refers to the empty vector that is the same as the MSRTG.3144.1 interference vector.

[0053] Table 1 Recommended infection volumes and amounts of infection reagents for different cell culture systems

[0054]

[0055] 3. Total RNA extraction from dermal fibroblasts

[0056] Extract total RNA from dermal fibroblast cell lines with a cell confluence of 90%; discard DMEM complete medium, add 1 mL preheated PBS to wash three times; add 1 mL Trizol to lyse the cells on ice for 5 min, and centrifuge at 12000 rpm and 4°C for 5 min; take the supernatant, transfer to a new 1.5 centrifuge tube, add 200 μL chloroform, mix well, let stand on ice for 10 min, and centrifuge at 12000 rpm and 4°C for 5 min; discard the supernatant, add 1 mL of 75% by volume ethanol, blow off the precipitate, and centrifuge at 7500 rpm and 4°C for 10 min; discard the supernatant, air-dry at room temperature or air-dry, and add 20 μL ddH2O; obtain total RNA from dermal fibroblasts and store at -80°C for later use.

[0057] It should be noted that the dermal fibroblasts from which total RNA was extracted were cultured in six-well plates.

[0058] The reason for air drying or drying at room temperature is that the RNA sample should not be too dry.

[0059] 4. qRT-PCR detection

[0060] In the previous study, the present invention has performed random qRT-PCR verification on the sequencing data, see doi: 10.3389 / fgene.2021.678825, so here only the key lncRNAs and their target genes obtained by screening are verified by qRT-PCR. The specific method is as follows:

[0061] The total RNA of the dermal fibroblasts extracted above was reverse transcribed using the PrimeScriptTM RT reagent Kit with gDNA Eraser kit from Takara Company. The qRT-PCR reaction system is shown in Table 2 to obtain the cDNA template. The obtained cDNA template and primers were prepared according to Table 3, and lncRNA and target genes were quantified using β-actin as an internal reference. The reaction procedure is shown in Table 4; Application 2 -△△CT The relative expression calculation formula was used to calculate the obtained quantitative data of lncRNA and target genes; Pearson correlation analysis was used to calculate the correlation between the relative expression of lncRNA and target genes, and Graphpadprisim 8.0 was used to visualize the generated data sets.

[0062] Among them, the primers used in the present invention were designed by Sangon Biotechnology (Shanghai) Co., Ltd., see Table 5.

[0063] Table 2 qRT-PCR reaction system

[0064]

[0065] Table 3 Reverse transcription reaction system

[0066]

[0067] Note: The reaction procedure is 37℃ 15min, 85℃ 5sec.

[0068] Table 4 qRT-PCR reaction procedure

[0069]

[0070] Table 5 lncRNA and mRNA primer sequence information

[0071]

[0072] 5. DNA staining method to detect dermal fibroblast cell cycle

[0073] Use trypsin containing EDTA to digest the target cells, collect the digested cells by centrifugation at 1500rpm for 5min; discard the supernatant, wash the cells once with PBS, and collect them by centrifugation at 1500rpm for 5min; add 500μL of 70% pre-cooled ethanol to the collected cell pellet for fixation overnight; centrifuge at 1500rpm for 5min after fixation; discard the supernatant, add pre-heated PBS to resuspend the cells, and centrifuge at 1500rpm for 5min; discard the supernatant, add 100μL RNase A solution to resuspend the cells, and bathe at 37℃ for 30min; then add 400μL PI staining solution and mix well, incubate at 4℃ in the dark for 30min; detect on the computer. Image J software processing. Among them, overnight refers to time ≥12h.

[0074] Cell proliferation index = (S+G2 / M) / (G0 / G1+S+G2 / M)%.

[0075] 6. CCK8 assay to detect proliferation of dermal fibroblasts

[0076] The target cells were digested with trypsin containing EDTA, and the digested cells were collected by centrifugation at 1500 rpm for 5 min; the supernatant was discarded, and the cells were washed once with PBS and collected by centrifugation at 1500 rpm for 5 min; DMEM / F12 medium containing 10% serum and antibody by mass percentage was added to the precipitate and mixed well, 100 μL of the cell suspension was inoculated into a 96-well plate, and 2×10 3Each well was cultured at 37°C and 5% CO2 by volume in an incubator. Every 24 hours, 10 μL of CCK8 solution was added to 3 wells and the cells were incubated at 37°C and 5% CO2 by volume in an incubator for 2 hours. The absorbance at 450 nm was measured using an enzyme-labeled instrument.

[0077] 7. Scratch test to detect dermal fibroblast migration

[0078] Before the scratch test, you need to use a marker to draw multiple marking lines horizontally on the back of the six-well plate with an interval of 0.5 cm; inoculate the transfected cells into the six-well plate with the drawn interval lines, and culture them in a 37°C, 5% CO2 incubator until the cell confluence reaches 100%, and then perform the scratch test; use a 200μL gun tip to scratch perpendicular to the marking line; wash with preheated PBS three times after the scratch; add serum-free DMEM / F12 culture medium and culture in a 37°C, 5% CO2 incubator. Select 0h and 24h for photography and observation, use Imagej software to calculate the scratch area, and calculate the cell migration rate. The calculation formula of the migration rate is: migration rate = (0h blank area-24h blank area) / 0h blank area.

[0079] result

[0080] 1. Construction of dermal fibroblast cell line

[0081] The FITC protein fluorescence results of each experimental group are as follows Figure 1 shown. Figure 1 The results showed that all cells in the experimental group emitted green fluorescence and had normal morphology, indicating that the transfection effect was good.

[0082] The results of qRT-PCR showed that the relative expression levels of shMSTRG-3144.1_1 and shMSTRG-3144.1_2 in dermal fibroblasts were significantly lower than those in the shRNA_NC and black groups, indicating that the stable transfection of lncRNA MSTRG-3144.1 into dermal fibroblasts was successfully constructed. In addition, shMSTRG-3144.1_2 had a better interference effect than shMSTRG-3144.1_1, and the lentiviral vector shMSTRG-3144.1_2 was subsequently selected for testing.

[0083] Among them, the nucleotide sequence of lncRNA MSTRG-3144.1 is shown in SEQ ID NO.1:

[0084] CTCATACTTACCTGGCAGGGGAGATACCATGATCACGAAGGTGGTTTTCCCAGGGCGAGGCTTATCCATTGCACTCCGGATGTGCTGACCCCTGCGATTTCCCCAAATGTGGGAAACTCGACTGCATAATTTGTGTTGGATCCCTGGGTCAGGAAGATCCCCTG GAGGAGGGCATGGCAATCCACTCCAGTGTTCCTGCCTGGAGAATCCTGTATATACAGGGGAGCCTGGCGGGCTACAGTCCATAGGGTCACTAGAGTCAACACAACTGAAGTGACTTAGCATGCACACAAGAAACTGCTACAACACTCCAGACCTTCAGCCAAG.

[0085] 2. qRT-PCR detection THEM4 / 5 Expression at the dermal fibroblast level

[0086] qRT-PCR results Figure 2 shown.

[0087] Figure 2 The results showed that in the shMSTRG.3144.1_2 dermal fibroblast interfering cell line, THEM4 and THEM5 The relative expression of lncRNA MSTRG.3144.1 in dermal fibroblasts was significantly different from that in the corresponding shRNA_NC group, P<0.001. THEM4 and THEM5 There is a positive correlation, which has a regulatory effect at the mRNA level.

[0088] 3. DNA staining method to detect dermal fibroblast cell cycle

[0089] DNA staining method was used to analyze the cell cycle of dermal fibroblasts. Figure 3 As shown in A, it was found that most cells interfered with lncRNA MSTRG.3144.1 stayed in the G0 / G1 phase, and the transition from the G0 / G1 phase to the S phase and G2 / M phase was inhibited, and the cell proliferation index was significantly reduced. Figure 3 B- Figure 3 As shown in C. This indicates that interfering with lncRNA MSTRG.3144.1 can inhibit the transition from G0 / G1 phase to S phase and G2 / M phase, inhibit the cell cycle process, and thus inhibit cell proliferation.

[0090] 4. Detection of proliferation of dermal fibroblasts by CCK8 method

[0091] The results of CCK8 assay are as follows Figure 4 shown.

[0092] Figure 4 The results showed that the cell proliferation level of dermal fibroblasts interfered with lncRNA MSTRG.3144.1 was significantly reduced, P<0.01. The results obtained were consistent with the experimental results of 4.3.3 DNA staining method for detecting cell cycle, indicating that interfering with lncRNA MSTRG.3144.1 can inhibit cell proliferation.

[0093] 5. Cell scratch test to detect the migration of dermal fibroblasts

[0094] The results of cell scratch test were as follows Figure 5 shown. Figure 5 The cell migration result detected by the cell scratch test in the present invention, wherein: Figure 5 A in the figure is the result of cell scratch test; Figure 5 B in the figure is the cell migration rate of dermal fibroblast cell line, * indicates P < 0.05; Figure 5 C in the figure is the result of detecting the proliferation of dermal fibroblasts after 24 hours of serum-free culture using the CCK-8 method.

[0095] Figure 5 The results showed that the migration rate of the shRNA_NC group was greater than that of the shMSTRG.3144.1_2 group in dermal fibroblasts, and the difference between the two groups was significant (P<0.05). This indicates that interfering with lncRNA MSTRG.3144.1_2 inhibits the migration of dermal fibroblasts.

[0096] In summary, lncRNA MSTRG.3144.1 can promote the migration of dermal fibroblasts.

[0097] The present invention established shMSTRG.3144.1_1, shMSTRG.3144.1_2, and shRNA_NC interference stably transformed dermal fibroblast cell lines, and qRT-PCR detection and screening of shMSTRG.3144.1_2 as the best interference vector.

[0098] The qRT-PCR test results of the present invention show that lncRNA MSTRG.3144.1 has a significant THEM4 , THEM5 The results of the DNA staining and CCK8 assays of the present invention show that interfering with lncRNA MSTRG.3144.1 can inhibit cell proliferation by regulating the cell cycle process. The results of the cell scratch assay of the present invention show that interfering with lncRNA MSTRG.3144.1 inhibits cell migration.

[0099] In organisms, lncRNA has diverse biological functions. It can act as a scaffold molecule to connect proteins and chromatin, causing structural remodeling of chromatin; it can activate or inhibit gene transcription by recruiting transcription factors to the gene promoter region or competitively binding with the promoter region transcription factors; it can also bind to mRNA to regulate its translation, regulate shearing, and degrade mRNA. Studies have found that lncRNA KB-1980E6.3 can enhance the stability of c-Myc mRNA by binding to IGF2BP1, identifying the instability determinant cluster of the m6A-modified c-Myc coding region. lncRNA GClnc1 recruits WDR5 and KAT2A complexes to the promoter region of the SOD2 gene, enriching this region and H3K9ac, thereby promoting SOD2 gene expression. Among them, the full name of SOD2 is superoxide dismutase 2. The full name of H3K4me3 is histone H3 lysine 4 trimethylation, H3K4me3. The full name of H3K9ac is histone H3 lysine 9 acetylation.

[0100] The results of the present invention found that lncRNA MSTRG.3144.1 mediates THEM4 and THEM5 Involved in the development of secondary hair follicles. THEM4 and THEM5 Transcription factors affect its transcription, as well as THEM4 and THEM5 The half-life of lncRNA MSTRG.3144.1 and its stability regulation remain to be explored. THEM4 and THEM5 The expression and protein translation are the key to subsequent experimental verification and are also issues worth considering.

[0101] It should be noted that when the present invention involves a numerical range, it should be understood that the two endpoints of each numerical range and any numerical value between the two endpoints can be selected. In order to avoid redundancy, the present invention describes a preferred embodiment.

[0102] Although preferred embodiments of the present invention have been described, those skilled in the art may make additional changes and modifications to these embodiments once they understand the basic inventive concepts, and all such changes and modifications fall within the scope of the present invention.

Claims

1. A cashmere goat lncRNA, characterized in that: The nucleotide sequence of the cashmere goat lncRNA is shown as SEQ ID NO.

1.

2. The cashmere goat lncRNA interference vector according to claim 1, characterized in that The cashmere goat lncRNA interference vector is the cashmere goat lncRNA shRNA interference vector.

3. The use of the interference vector of the cashmere goat lncRNA according to claim 2 in reducing the growth of cashmere goats, characterized in that: The cashmere goat lncRNA interference vector is used to inhibit the expression of the cashmere goat lncRNA, thereby reducing the growth of cashmere goat cashmere.

4. The use according to claim 3, characterized in that: The development of hair follicles is inhibited by the interference vector of the cashmere goat lncRNA, thereby reducing the growth of cashmere goat cashmere.

5. The use according to claim 4, characterized in that: Inhibit the development of hair follicles and reduce cashmere growth in cashmere goats by any of the following methods: Inhibiting the expression of the cashmere goat lncRNA to inhibit the dermal fibroblast cell cycle; Inhibiting the expression of the cashmere goat lncRNA to inhibit the proliferation of dermal fibroblasts; Inhibiting the expression of the cashmere goat lncRNA to inhibit the migration of dermal fibroblasts; Inhibiting the expression of the cashmere goat lncRNA to promote the expression of mRNA related to the proliferation or migration of dermal fibroblasts, wherein the mRNA includes THEM4 , THEM5 .

6. The use according to claim 5, characterized in that: The dermal fibroblasts are dermal fibroblasts that grow and develop in the early stage of the hair follicles of cashmere goats.

7. The use according to claim 5, characterized in that: The proliferation or migration of dermal fibroblasts is used to promote the formation of hair follicle dermal condensates and dermal papillae, thereby promoting the growth of cashmere goats' cashmere.

8. The use according to claim 5, characterized in that: The cashmere goat lncRNA interference vector is used to prepare a product for inhibiting the proliferation or migration of dermal fibroblasts.